Study of Platelet Population Changes Under Circulatory Support With ECMO

Recruiting now

Conditions studied: Cardiac Failure, Respiratory Failure

In brief

Advances in flow cytometry techniques have led to a better understanding of platelet phenotypes and have revealed the existence of four major platelet populations with distinct functional properties (native, proaggregating, procoagulating, or apoptotic). These phenotypes have a significant impact on the hemostatic capacity of blood platelets, and a proportional change in these populations during ECMO treatment could, at least in part, contribute to the observed complications.

Key facts

Study ID

NCT07334457

Run by

University Hospital, Strasbourg, France

People needed

75

Starts

2025-03-11

Expected to finish

2027-03-11

Last updated by the study team

2026-01-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patient (≥18 years) treated in one of the intensive care units of the Anesthesia and Intensive Care Department at Strasbourg University Hospital.
• Implanted with veno-arterial or veno-venous ECMO within the previous 24 hours.

You may not qualify if…

• Subject who has expressed their opposition to participating in the study.
• Subject under legal protection.
• Subject under guardianship or curatorship.

Where it is running

• Service d'anesthésie-réanimation - CHU de Strasbourg - France — Strasbourg, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.